Skip to main content
. 2019 Oct 11;7(1):e000795. doi: 10.1136/bmjdrc-2019-000795

Table 1.

Trends of diabetic foot complications among patients with T2D

Year 2007 2008 2009 2010 2011 2012 2013 2014 P for trend
Patients with DFC 23 068 26 039 27 368 28 729 29 770 30 007 30 332 30 783
T2D population 1 115 556 1 192 004 1 269 496 1 339 223 1 404 474 1 472 448 1 535 613 1 556 988
 DFCs prevalence, %
 (95% CI)
2.07
(2.04 to 2.09)
2.18
(2.16 to 2.21)
2.16
(2.13 to 2.18)
2.15
(2.12 to 2.17)
2.12
(2.10 to 2.14)
2.04
(2.02 to 2.06)
1.98
(1.95 to 2.00)
1.98
(1.96 to 2.00)
0.024
 Cost*: DFCs/T2D
 ratio (%)
8.8/2.7
330
8.8/2.7
325
9.1/2.7
335
9.1/2.7
338
9.2/2.7
336
9.0/2.7
337
8.9/2.7
328
8.5/2.6
320
 0.659
LEAs (per 1000 subjects with T2D) 2.85 2.91 2.72 2.59 2.68 2.29 2.07 2.06 0.001
 Minor LEA 1.25 1.33 1.29 1.24 1.33 1.14 1.09 1.09 0.019
 Major LEA 1.60 1.57 1.43 1.35 1.35 1.15 0.98 0.98 <0.001
 Major/total LEAs (%) 56.2 54.1 52.7 52.3 50.5 50.3 47.3 47.4 <0.001

*Cost unit=US$1000 per one person-years.

DFC, diabetic foot complication; LEA, lower extremity amputations; T2D, type 2 diabetes.